Transfusion-transmitted bacterial infections-haemovigilance data of German blood establishments (1997-2010)

Transfusion Medicine and Hemotherapy

Volumn 38, Issue 4, 2011, Pages 266-271

  Funk, Markus B ^a   Lohmann, Annette ^a   Guenay, Serife ^a   Henseler, Olaf ^b   Heiden, Margarethe ^b   Hanschmann, Kay Martin ^a   Keller Stanislawski, Brigitte ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b Department of Transfusion Medicine ^*  (Germany)

Author keywords

Blood components; Frequency; Haemovigilance; Limitation of platelet shelf life; Pathogenicity; Pre donation sampling; Severity; TTBI

Indexed keywords

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

ARTICLE; BACTERIAL INFECTION; BLOOD SAFETY; BLOOD TRANSFUSION; DISEASE ASSOCIATION; ERYTHROCYTE; IMMUNOCOMPROMISED PATIENT; NONHUMAN; ONCOLOGICAL PARAMETERS; SCREENING TEST;

EID: 80052216628     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000330372     Document Type: Article

References (16)

1. International Haemovigilance Network: Definition of Haemovigilance. www.ihn-org.net.
2. Serios Hazards of Transfusion (SHOT): SHOT Annual Reports and Summaries. www.shotuk.org/home.
3. Annual Hemovigilance Report swissmedic 2005/2006: www.swissmedic.ch/ haemo.asp.
4. Dumont LJ, Kleinman S, Murphy JR, Lippincott R, Schuyler R, Houghton J, Metzel P: Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50:589-599.
5. Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Hervé P: Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002;42:1356-1364.
6. Keller-Stanislawski B, Lohmann A, Günay S, Heiden M, Funk MB: The German Haemovigilance System-reports of serious adverse transfusion reactions between 1997 and 2007. Transfus Med 2009; 19:340-349.
7. Ramírez-Arcos S, Jenkins C, Dion J, Bernier F, Delage G, Goldman M: Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007;47:421-429.
8. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR: Transfusiontransmitted bacterial infection in the United States, 1998. through 2000. Transfusion 2001;41:1493-1499. (Pubitemid 34072672)
9. Perez P, Salmi LR, Folléa G, Schmit JL, de Barbeyrac B, Sudre P, Salamon R; BACTHEM Group; French Haemovigilance Network: Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion 2001;41:862-872. (Pubitemid 32642757)
10. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ; American Red Cross Regional Blood Centers: Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007;47:1134-1142. (Pubitemid 46934307)
11. Schrezenmeier, H, Walther-Wenke G, Müller TH, et al: Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007;47:644-652. (Pubitemid 46449625)
12. Satake M, Mitani T, Oikawa S, Nagumo H, Sugiura S, Tateyama H, Awakihara S, Mitsutomi Y, Muraoka M, Tadokoro K: Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan. Transfusion 2009;49:2152-2157.
13. Mastronardi C, Martincic I, Ramírez-Arcos S: Implementation of a proficiency testing programme for bacterial screening in platelet preparations in Canada. Vox Sang 2007;93:131-138. (Pubitemid 47228501)
14. Wagner SJ: Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004;86:157-163. (Pubitemid 38529504)
15. de Korte D, Curvers J, de Kort WL, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH: Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006;46:476-485. (Pubitemid 43334104)
16. Robillard P, Delage G, Karl Itaj N, Goldman M: Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection. Transfusion 2011; doi: 10.1111/j.1537-2995.2010.03001.x.